Skip to Main Content

Paper Details

External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population.
Eur J Epidemiol
2
2021
COVID-19, SARS-CoV, SARS-CoV-2, participants, persons, women
Author NameAffiliation
Albert HofmanHarvard T.H. Chan School of Public Health
Albert HofmanHarvard T.H. Chan School of Public Health
  • 1 - 2

Datasets

Release 1.2